Press Releases on January 8, 2024 - EIN Presswire - Press Release Distribution Service

Published on January 8, 2024 - 12:30 GMT

Gildan Activewear Board of Directors Issues Open Letter to Shareholders and Sets Record Straight on Browning West’s Misguided ...

CEO’s False Narrative Designed to Hide His Ineffective Leadership, Lack of Vision and High-Risk Go-Forward Strategy Questionable Behaviors Underscore Why New Leadership is Required for Gildan to Reach its Full Potential The Board of Directors is currently …

Distribution channels: Companies, Consumer Goods ...

Published on January 8, 2024 - 12:30 GMT

Le conseil d’administration de Les Vêtements de Sport Gildan adresse une lettre ouverte aux actionnaires et remet les pendules à l’...

Faux arguments du chef de la direction visant à cacher son leadership inefficace, son manque de vision et sa stratégie de rentabilité à risque élevé Des comportements douteux mettent en évidence les raisons pour lesquelles il est nécessaire de renouveler …

Distribution channels: Companies, Consumer Goods ...

Published on January 8, 2024 - 12:30 GMT

Endpoint Detection and Response Market Expected to Reach US$ 32.4 Billion by 2034, rising at a whopping 23.2% CAGR: Future Market ...

NEWARK, Del, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The endpoint detection and response market is estimated to be worth US$ 4.0 billion in 2024 and is projected to be valued at US$ 32.4 billion in 2034. Between 2024 and 2034, the industry is expected to …

Distribution channels: Book Publishing Industry ...

Published on January 8, 2024 - 12:30 GMT

BlackDice and Orion Telekom Collaboration Marks a Significant Leap Forward in Cybersecurity

LEEDS, United Kingdom, Jan. 08, 2024 (GLOBE NEWSWIRE) -- BlackDice Holdings Corp. ("BlackDice" or the “Company”), an emerging player in AI-powered cybersecurity for the Telecom industry joins forces with Orion Telekom, Serbia's premier …

Distribution channels:

Published on January 8, 2024 - 12:30 GMT

VitalHub Corp. Benefitting From Recent UK Government Initiatives

TORONTO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX:VHI) (OTCQX:VHIBF) is pleased to announce the United Kingdom (UK) government’s investment in System Coordination Centre (SCC) medical technology, aimed at …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 8, 2024 - 12:30 GMT

Telehealth & Telemedicine Market is Expected to Reach $285.7 Billion | MarketsandMarkets.

Chicago, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Telehealth & Telemedicine market in terms of revenue was estimated to be worth $120.4 Billion in 2023 and is poised to reach $285.7 billion by 2028, growing at a CAGR of 23.2% from 2023 to 2028 according to a …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 8, 2024 - 12:30 GMT

Photovoltaic Glass Market to garner US$ 237.16 Billion by 2034: Fact.MR Report

Rockville , Jan. 08, 2024 (GLOBE NEWSWIRE) -- The global photovoltaic glass market,estimated at US$ 21.24 billion for 2024, is projected to expand at a remarkable CAGR of 26.8% from 2024 to 2034. The market has observed robust development due to an upsurge …

Distribution channels: Business & Economy ...

Published on January 8, 2024 - 12:30 GMT

Churchill Resources to Present at the Emerging Growth Conference January 11, 2024

TORONTO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Churchill Resources Inc. (“Churchill” or the “Company”) (TSXV: CRI) is pleased to announce that it will present an update on the Taylor Brook Nickel Project at the Emerging Growth Conference at 1:45 - 2:15 Eastern …

Distribution channels:

Published on January 8, 2024 - 12:30 GMT

Enovix and Group14 Announce Collaboration to Develop Best-in-Class Silicon Batteries

FREMONT, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), an advanced silicon battery company, and Group14 Technologies, a leading manufacturer and supplier of active silicon battery material, today announced their …

Distribution channels: Companies, Media, Advertising & PR ...

Published on January 8, 2024 - 12:30 GMT

Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference

CARLSBAD, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that …

Distribution channels:

Published on January 8, 2024 - 12:30 GMT

Arbutus Announces 2024 Corporate Objectives and Provides Financial Update

Additional data from two on-going Phase 2a clinical trials evaluating imdusiran, our RNAi therapeutic, as a cornerstone therapy in combination with other compounds expected in 2024 Initiation of a third Phase 2a clinical trial evaluating imdusiran and an …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 12:30 GMT

Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Neurodevelopmental ...

NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...

Published on January 8, 2024 - 12:30 GMT

Zevra Therapeutics Receives FDA Acceptance of Resubmission of NDA for Arimoclomol as a Treatment for Niemann-Pick Disease Type C

Arimoclomol NDA has been assigned a PDUFA action date of June 21, 2024 CELEBRATION, Fla., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a rare disease therapeutics company, today announced that the U.S. …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 8, 2024 - 12:30 GMT

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

Orchestra BioMed and Medtronic, Inc., have an exclusive strategic collaboration for development and commercialization of AVIM therapy for hypertensive pacemaker population, which is estimated to be more than 750,000 patients annually worldwide NEW HOPE, Pa …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 12:30 GMT

Xilio Therapeutics Highlights Recent Advances Across Clinical Pipeline and Encouraging Preliminary Phase 1 Safety Data for XTX301, ...

Dosing XTX301 at 45 ug/kg once every three weeks (dose level 3) in ongoing Phase 1 trial, nearly 100x the maximum tolerated dose of rhIL-12, with no dose-limiting toxicities observed to date Initiated patient dosing in Phase 1/2 trial for XTX101, a tumor- …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 8, 2024 - 12:30 GMT

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

EMERYVILLE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today the Board of Directors has named Owen Hughes as Chief Executive Officer and Jack L. Wyszomierski as Chairman of the Board …

Distribution channels: Companies, Technology ...

Published on January 8, 2024 - 12:30 GMT

Surgery Partners, Inc. Reaffirms 2023 Full Year Guidance and Provides 2024 Initial Adjusted EBITDA Outlook

BRENTWOOD, Tenn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Members of management of Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, will be meeting with …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on January 8, 2024 - 12:30 GMT

Abeona Therapeutics Announces $50 Million Credit Facility

CLEVELAND, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it has entered into a $50 million credit facility with the Avenue Venture Opportunities Fund, L.P. The credit agreement, which has a term of three and …

Distribution channels: Technology ...

Published on January 8, 2024 - 12:30 GMT

Morgan Stanley Initiates Research Coverage on Mondee

AUSTIN, Texas, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading AI travel technology company and marketplace with a portfolio of global platforms in the leisure and corporate travel sectors, …

Distribution channels: Business & Economy, Technology ...

Published on January 8, 2024 - 12:30 GMT

Vivos Therapeutics Sees Positive Preliminary Metrics Following Unprecedented FDA 510(k) Clearance of the Company’s Proprietary ...

New Dentist Inquiries Jumped 600% and Signed Dentist Enrollment Contracts up 38% Sequentially Over Q3 CARE Oral Medical Device Unit Orders Increased 26% Following FDA Clearance LITTLETON, Colo., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ( …

Distribution channels: